Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND5 pseudogene 17 (MTND5P17) is classified as a nuclear pseudogene and does not encode a functional protein. It is homologous to the mitochondrial gene MT-ND5, which encodes a subunit of mitochondrial respiratory chain complex I involved in NADH:ubiquinone oxidoreductase activity, essential for mitochondrial electron transport and ATP production. However, MTND5P17 contains sequence features (such as premature stop codons) that prevent production of a functional protein, so it has no known functional role in energy metabolism, does not participate in mitochondrial complex I assembly, and is not implicated in disease pathology or therapeutic targeting. Pseudogenes such as MTND5P17 may occasionally be transcribed but do not yield functional proteins. They do not play a recognized role in major disease pathways, drug interactions, therapeutic mechanisms, or biomarker discovery. MTND5P17 is a pseudogene—a genomic DNA sequence similar to a gene but nonfunctional due to mutations such as frameshifts or premature stop codons. Although the parent MT-ND5 gene is critical for mitochondrial function and implicated in diseases such as Leigh syndrome and MELAS, the pseudogene version does not encode an active enzyme or receptor. Nuclear pseudogenes of mitochondrial genes are well-documented; they can be detected by PCR due to sequence similarity, but their products are not functional proteins and do not contribute to mitochondrial activity. There is no evidence that MTND5P17 is involved in any therapeutic mechanism, nor are there known drugs that act on it, nor any biomarker role or disease association. Its aliases and identifiers include MTND5P17 (GeneCards, NCBI Gene: 100873353) and MT-ND5 pseudogene 17 (Ensembl: ENSG00000236626). If you are seeking information on the functional mitochondrial gene (MT-ND5), refer to its role in oxidative phosphorylation and mitochondrial disease; however, MTND5P17 specifically refers to a noncoding pseudogene and is not itself a molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND5 pseudogene 17 (MTND5P17).